Yuval Cohen Corbus Pharmaceuticals Holdings, Inc. (CRBP) insider trading activity

CRBP Quotes by TradingView

Yuval Cohen is Chief Executive Officer of Corbus Pharmaceuticals Holdings, Inc.. Currently has a direct ownership of 138,187 shares of CRBP, which is worth approximately $1.13 Million. The most recent transaction as insider was on Feb 14, 2025, when has been sold 7,134 shares (Common Stock, par value $0.0001 per share) at a price of $8.76 per share, resulting in proceeds of $62,493. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 138K
78.95% 3M change
63.73% 12M change
Total Value Held $1.13 Million

Yuval Cohen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 14 2025
SELL
Open market or private sale
$62,493 $8.76 p/Share
7,134 Reduced 4.91%
138,187 Common Stock, par valu...
Jan 31 2025
BUY
Grant, award, or other acquisition
-
68,100 Added 31.91%
145,321 Common Stock, par valu...
Jun 18 2024
SELL
Open market or private sale
$968,901 $42.24 p/Share
22,938 Reduced 22.9%
77,221 Common Stock, par valu...
Jun 18 2024
BUY
Exercise of conversion of derivative security
$254,035 $16.12 p/Share
15,759 Added 15.38%
86,722 Common Stock, par valu...
Jun 17 2024
SELL
Open market or private sale
$510,960 $46.02 p/Share
11,103 Reduced 11.63%
84,400 Common Stock, par valu...
Jun 17 2024
BUY
Exercise of conversion of derivative security
$190,194 $17.13 p/Share
11,103 Added 11.41%
86,170 Common Stock, par valu...
Jun 14 2024
SELL
Open market or private sale
$1,470,833 $50.17 p/Share
29,317 Reduced 25.78%
84,400 Common Stock, par valu...
Jun 14 2024
BUY
Exercise of conversion of derivative security
$269,130 $9.18 p/Share
29,317 Added 23.23%
96,887 Common Stock, par valu...
Feb 12 2024
BUY
Grant, award, or other acquisition
-
73,947 Added 46.7%
84,400 Common Stock, par valu...
Jan 26 2024
BUY
Exercise of conversion of derivative security
$35,679 $4.97 p/Share
7,179 Added 50.0%
7,179 Common Stock
Aug 10 2022
BUY
Open market or private purchase
$988 $0.26 p/Share
3,800 Added 3.72%
98,230 Common Stock
May 16 2022
BUY
Open market or private purchase
$2,625 $0.25 p/Share
10,500 Added 10.01%
94,430 Common Stock
Mar 09 2022
BUY
Open market or private purchase
$3,182 $0.37 p/Share
8,600 Added 9.29%
83,930 Common Stock
Nov 11 2020
BUY
Open market or private purchase
$5,130 $1.21 p/Share
4,240 Added 5.33%
75,330 Common Stock
YC

Yuval Cohen

Chief Executive Officer
Norwood, MA

Track Institutional and Insider Activities on CRBP

Follow Corbus Pharmaceuticals Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRBP shares.

Notify only if

Insider Trading

Get notified when an Corbus Pharmaceuticals Holdings, Inc. insider buys or sells CRBP shares.

Notify only if

News

Receive news related to Corbus Pharmaceuticals Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRBP